Novavax, Inc. is a company in the U.S. stock market and it is a holding in 99 U.S.-traded ETFs. NVAX has around 5.0M shares in the U.S. ETF market. The largest ETF holder of NVAX is the Vanguard Small-Cap ETF (VB), with approximately 673.23K shares. Investors may also find of interest that the ETF with the largest allocation to NVAX stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 3.57%. On average, U.S. ETFs allocate 0.41% of NVAX to their portfolios.

Additionally, NVAX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVAX as a holding is the Columbia Research Enhanced Core ETF (RECS), with a return of 30.04%.